Involvement of urokinase‐type plasminogen activator system in cancer: An overview AH Mekkawy, MH Pourgholami, DL Morris Medicinal research reviews 34 (5), 918-956, 2014 | 164 | 2014 |
Urokinase plasminogen activator system as a potential target for cancer therapy AH Mekkawy, DL Morris, MH Pourgholami Future Oncology 5 (9), 1487-1499, 2009 | 105 | 2009 |
Minocycline inhibits growth of epithelial ovarian cancer MH Pourgholami, AH Mekkawy, S Badar, DL Morris Gynecologic oncology 125 (2), 433-440, 2012 | 46 | 2012 |
A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study SJ Valle, J Akhter, AH Mekkawy, S Lodh, K Pillai, S Badar, D Glenn, ... European Journal of Surgical Oncology 47 (1), 115-122, 2021 | 45 | 2021 |
The combination of bromelain and acetylcysteine (BromAc) synergistically inactivates SARS-CoV-2 J Akhter, G Quéromès, K Pillai, V Kepenekian, S Badar, AH Mekkawy, ... Viruses 13 (3), 425, 2021 | 40 | 2021 |
Interaction between urokinase receptor and heat shock protein MRJ enhances cell adhesion C Edo De Bock, Z Lin, AH Mekkawy, JA Byrne, Y Wang International journal of oncology 36 (5), 1155-1163, 2010 | 30 | 2010 |
Enhancing the potency of chemotherapeutic agents by combination with bromelain and N-acetylcysteine-an in vitro study with pancreatic and hepatic cancer cells K Pillai, AH Mekkawy, J Akhter, S Badar, L Dong, AI Liu, DL Morris American Journal of Translational Research 12 (11), 7404, 2020 | 26 | 2020 |
Monepantel induces autophagy in human ovarian cancer cells through disruption of the mTOR/p70S6K signalling pathway F Bahrami, MH Pourgholami, AH Mekkawy, L Rufener, DL Morris American journal of cancer research 4 (5), 558, 2014 | 26 | 2014 |
Physical and chemical characteristics of mucin secreted by pseudomyxoma peritonei (PMP) K Pillai, J Akhter, A Mekkawy, TC Chua, DL Morris International journal of medical sciences 14 (1), 18, 2017 | 24 | 2017 |
HAX1 Augments Cell Proliferation, Migration, Adhesion, and Invasion Induced by Urokinase‐Type Plasminogen Activator Receptor AH Mekkawy, DL Morris, MH Pourgholami Journal of Oncology 2012 (1), 950749, 2012 | 22 | 2012 |
Novel protein interactors of urokinase-type plasminogen activator receptor AH Mekkawy, CE De Bock, Z Lin, DL Morris, Y Wang, MH Pourgholami Biochemical and Biophysical Research Communications 399 (4), 738-743, 2010 | 22 | 2010 |
Role of human nucleoside transporters in pancreatic cancer and chemoresistance CJ Carter, AH Mekkawy, DL Morris World Journal of Gastroenterology 27 (40), 6844, 2021 | 18 | 2021 |
Human Sprouty1 suppresses growth, migration, and invasion in human breast cancer cells AH Mekkawy, MH Pourgholami, DL Morris Tumor Biology 35, 5037-5048, 2014 | 18 | 2014 |
Addition of bromelain and acetylcysteine to gemcitabine potentiates tumor inhibition in vivo in human colon cancer cell line LS174T AH Mekkawy, K Pillai, S Badar, J Akhter, K Ke, SJ Valle, DL Morris American Journal of Cancer Research 11 (5), 2252, 2021 | 11 | 2021 |
Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia E Abadir, PA Silveira, RE Gasiorowski, M Ramesh, A Romano, ... Blood Advances 4 (7), 1206-1216, 2020 | 9 | 2020 |
Distinguishing human peripheral blood CD16+ myeloid cells based on phenotypic characteristics PD Fromm, PA Silveira, JL Hsu, MS Papadimitrious, TH Lo, X Ju, ... Journal of Leukocyte Biology 107 (2), 323-339, 2020 | 9 | 2020 |
The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 study K Ke, K Pillai, AH Mekkawy, J Akhter, S Badar, SJ Valle, DL Morris Discover Oncology 12 (1), 25, 2021 | 8 | 2021 |
Comparison of proteolytic, cytotoxic and anticoagulant properties of chromatographically fractionated bromelain to un-fractionated bromelain S Badar, M Azarkan, AH Mekkawy, J Akhter, K Pillai, R El Mahyaoui, K Ke, ... American Journal of Translational Research 13 (5), 4309, 2021 | 7 | 2021 |
Bromelain and acetylcysteine (BromAc®) alone and in combination with gemcitabine inhibit subcutaneous deposits of pancreatic cancer after intraperitoneal injection AH Mekkawy, K Pillai, H Suh, S Badar, J Akhter, V Kepenekian, K Ke, ... American journal of translational research 13 (12), 13524, 2021 | 7 | 2021 |
Human Sprouty1 Suppresses Urokinase Receptor‐Stimulated Cell Migration and Invasion AH Mekkawy, DL Morris International Scholarly Research Notices 2013 (1), 598251, 2013 | 7 | 2013 |